Wearable myopia device inhibits progression, axial elongation in children
A wearable myopia device significantly reduced myopic refractive error progression and axial elongation in children compared with published virtual control subjects, according to a Kubota Vision press release.
The prospective longitudinal trial included children between the ages of 10 and 17 years who used the study device approximately 1.5 hours per day 5 days per week for 6 months. Compared with the control cohort matched for age and ethnicity, cycloplegic refractive error progression at 12 months was projected out to 0.42 D less in the device-wearing group, and axial elongation was projected out to 0.21 mm less, the press release said.
“These new data ... demonstrate an inhibitory effect on the progression of myopia in this 6-month long-term study in children using a spectacle-type device less than 2 hours a day, 5 days a week,” Ryo Kubota, MD, PhD, chairman, president and CEO of Kubota Vision, said in the release, “The onset of myopia at a young age increases the risk of high myopia. We will continue accumulating evidence for Kubota Glass technology as a safe, effective and easy approach to control myopia.”
Read more about